Yonsei Med J.  2014 Jul;55(4):1058-1062. 10.3349/ymj.2014.55.4.1058.

Knowledge on Osteoporosis of Prescriber According to Level of Medical Institute

• Yoon BH
• Baek JH
• Lee YK
• Ha YC
• Koo KH

• KMID: 2130833
• DOI: http://doi.org/10.3349/ymj.2014.55.4.1058

Abstract

PURPOSE
There are gaps between the treatment guideline and clinical practice of osteoporosis showing low compliance. Although attitude and knowledge of prescriber have been known to be associated with the low compliance in real clinical practice, no study has assessed the knowledge of prescriber regarding osteoporosis in accordance to the level of medical institution. We compared the knowledge on osteoporosis of general practitioners with that of practitioners in a tertiary referral hospital.
MATERIALS AND METHODS
In May 2012, 40 general practitioners and 40 practitioners in a tertiary referral hospital were evaluated using a modified Facts on Osteoporosis Quiz.
RESULTS
The level of knowledge of general practitioners was similar with that of practitioners in a tertiary referral hospital (p=0.386). And, both groups were lack of knowledge of effect of physical exercise.
CONCLUSION
The level of knowledge on osteoporosis was not associated with the level of medical institute, and the effect of physical exercise should be stressed in an educational program on osteoporosis for practitioners.

Keyword

Osteoporosis; knowledge; level of medical institute

MeSH Terms

Adult
Attitude of Health Personnel
Exercise
Female
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
*Osteoporosis
Questionnaires

Figure

• 

  Fig. 1 The proportion of correct answer in each item between general practitioners and practitioners in a tertiary referral hospital (*p<0.05).

Reference

1. Park C, Ha YC, Jang S, Jang S, Yoon HK, Lee YK. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. 2011; 29:744–751.

2. Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol. 2007; 34:1551–1560.

3. Yoon HK, Park C, Jang S, Jang S, Lee YK, Ha YC. Incidence and mortality following hip fracture in Korea. J Korean Med Sci. 2011; 26:1087–1092.

4. Lee YK, Jang S, Jang S, Lee HJ, Park C, Ha YC, et al. Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int. 2012; 23:1859–1865.

5. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, et al. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev. 2002; 23:508–516.

6. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med. 1998; 338:736–746.

7. McClung MR. Therapy for fracture prevention. JAMA. 1999; 282:687–689.

8. Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010; 16:Suppl 3. 1–37.

9. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK, et al. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008; 149:404–415.

10. Dawson-Hughes B. National Osteoporosis Foundation Guide Committee. A revised clinician's guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab. 2008; 93:2463–2465.

11. Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Dawson-Hughes B, et al. Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int. 2007; 18:711–719.

12. Compston JE, Seeman E. Compliance with osteoporosis therapy is the weakest link. Lancet. 2006; 368:973–974.

13. Gong HS, Oh WS, Chung MS, Oh JH, Lee YH, Baek GH. Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. J Bone Joint Surg Am. 2009; 91:2376–2380.

14. Choi HJ, Shin CS, Ha YC, Jang S, Jang S, Park C, et al. Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab. 2012; 30:54–58.

15. Kim SR, Ha YC, Park YG, Lee SR, Koo KH. Orthopedic surgeon's awareness can improve osteoporosis treatment following hip fracture: a prospective cohort study. J Korean Med Sci. 2011; 26:1501–1507.

16. Lee YK, Nho JH, Ha YC, Koo KH. Persistence with intravenous zoledronate in elderly patients with osteoporosis. Osteoporos Int. 2012; 23:2329–2333.

17. Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int. 2007; 18:1023–1031.

18. Kamatari M, Koto S, Ozawa N, Urao C, Suzuki Y, Akasaka E, et al. Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Miner Metab. 2007; 25:302–309.

19. Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, et al. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int. 2006; 17:914–921.

20. Zhang RF, Chandran M. Knowledge of osteoporosis and its related risk factors among nursing professionals. Singapore Med J. 2011; 52:158–162.

21. Wilson RK, Tomlinson G, Stas V, Ridout R, Mahomed N, Gross A, et al. Male and non-English-speaking patients with fracture have poorer knowledge of osteoporosis. J Bone Joint Surg Am. 2011; 93:766–774.

22. Baek JH, Lee YK, Hong SW, Ha YC, Koo KH. Knowledge on osteoporosis in guardians of hip fracture patients. J Bone Miner Metab. 2013; 31:481–484.

23. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. 1990; 11:116–128.

24. Ailinger RL, Lasus H, Braun MA. Revision of the Facts on Osteoporosis Quiz. Nurs Res. 2003; 52:198–201.

25. Korea Women's Health and Osteoporosis Foundation. Korean Society of Osteoporosis. Korean Society of Gynecologic Endocrinology. Calcium and Vitamin D Recommendation. 2010.

26. Edelstein OE. What Do Israeli Osteoporotic Men Know and Do about Their Disease? J Osteoporos. 2011; 2011:719862.